NCT00632112

Brief Summary

Continuous albuterol has become the standard of care for patients in status asthmaticus. We have previously performed an in-vitro study comparing 4 different brands of continuous nebulizers. We now want to compare the in-vitro with the in-vivo performance of the brand we use. we hypothesize that there will be no difference between in-vivo and in-vitro results.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 29, 2008

Completed
1 day until next milestone

Study Start

First participant enrolled

March 1, 2008

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 10, 2008

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2009

Completed
Last Updated

June 5, 2009

Status Verified

June 1, 2009

Enrollment Period

1.3 years

First QC Date

February 29, 2008

Last Update Submit

June 3, 2009

Conditions

Asthma

Keywords

large volume nebulizer

Outcome Measures

Primary Outcomes (1)

  • Nebulizer solution output

    every 2 hours for first 6 hours

Eligibility Criteria

AgeUp to 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pediatric patients admitted to the Pediatric Intensive Care Unit due to status asthmaticus, requiring continuous albuterol nebulization.

You may qualify if:

  • Pediatric patients admitted to Pediatric Intensive Care Unit due to status asthmaticus, requiring continuous albuterol nebulization.

You may not qualify if:

  • Patients requiring invasive or non-invasive ventilation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arkansas Children's Hospital

Little Rock, Arkansas, 72202, United States

RECRUITING

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Ariel Berlinski, M.D.

    University of Arkansas

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ariel Berlinski, M.D.

CONTACT

501-364-1006berlinskiariel@uams.edu

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 29, 2008

First Posted

March 10, 2008

Study Start

March 1, 2008

Primary Completion

July 1, 2009

Last Updated

June 5, 2009

Record last verified: 2009-06

Locations

US(1)